Crossmark

Validation and modification of renal risk score for prediction of long-term kidney survival in patients with MPO-ANCA-associated glomerulonephritis

Crossref DOI link: https://doi.org/10.1007/s40620-024-02134-z

Published Online: 2024-11-22

Published Print: 2025-01-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Meng

Liu, Xia

Chen, Yinghua

Chen, Xin

Xu, Feng

Liu, Zhengzhao

Zhang, Haitao

Zeng, Caihong

Hu, Weixin
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (8210741)

Jiangsu Biobank of Clinical Resources (BM2015004-1)

National Natural Science Foundation of China (8210741)

Jiangsu Biobank of Clinical Resources (BM2015004-1)
License Information

Version of Record valid from 2024-11-22

Text and Data Mining valid from 2024-11-22

Version of Record valid from 2024-11-22
More Information

Article History

Received: 20 January 2024

Accepted: 7 October 2024

First Online: 22 November 2024

Declarations

:

: None.

: The study was approved by the ethics committee of Jinling Hospital (No. 2022DZKY-100–01), and was performed in accordance with the ethical standards in the 1964 Declaration of Helsinki and its later amendments.

: The present study complies with the guidelines for human studies. This study does not contain any studies with animals.

: The paper involved human participants. Informed written consent was obtained from all participants involved in the study for the use of their clinical data for research purposes.